419 results on '"Verstraete, Alain G."'
Search Results
2. Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients
3. Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit
4. Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method
5. Development, validation and application of an inductively coupled plasma – mass spectrometry method to determine cobalt in metal-on-metal prosthesis patients using volumetric absorptive microsampling
6. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on Two Routine Chemistry Analyzers
7. Automation in Microsampling
8. Subtherapeutic piperacillin concentrations in neurocritical patients
9. Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy
10. Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study
11. Development and validation of an ultra-high performance liquid chromatography – high resolution mass spectrometry method for the quantification of total and free teicoplanin in human plasma
12. Pretomanid-resistant tuberculosis
13. Δ9-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects following cannabis intake – A pilot study using illicit cannabis
14. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood
15. Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review
16. Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance
17. Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS
18. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay
19. Prescribing and dispensing guidelines for medicinal drugs affecting driving performance
20. Proficiency Testing for Meropenem and Piperacillin Therapeutic Drug Monitoring: Preliminary Results From the Belgian Society on Infectiology and Clinical Microbiology Pharmacokinetic–Pharmacodynamic Working Group
21. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood
22. The Results of the Roadside Drug Testing Assessment Project
23. Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme
24. Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome
25. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry Analyzers
26. Random and systematic errors in case–control studies calculating the injury risk of driving under the influence of psychoactive substances
27. Repeatability of oral fluid collection methods for THC measurement
28. Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method
29. Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS.
30. Prevalence of alcohol and other psychoactive substances in injured drivers: Comparison between Belgium and the Netherlands
31. Prevalence and Risk of Injury in Europe by Driving with Alcohol, Illicit Drugs and Medicines
32. Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples
33. Impaired hemoglobin scavenging during an acute HIV-1 retroviral syndrome
34. Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces
35. Exploration of the pre-analytical stability of β-lactam antibiotics in plasma and blood - implications for therapeutic drug monitoring and pharmacokinetic studies
36. Therapeutic drug monitoring of voriconazole: validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography
37. The toxicological challenges in the European research project DRUID
38. The modern trends in alcohol, drugs and driving research
39. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures
40. Effects of alcohol (BAC 0.5‰) and ecstasy (MDMA 100 mg) on simulated driving performance and traffic safety
41. Medicines and driving: evaluation of training and software support for patient counselling by pharmacists
42. Multicenter method evaluation of the ARK™ Methotrexate Immunoassay
43. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur).
44. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care.
45. A sensitive and high‐throughput quantitative liquid chromatography high‐resolution mass spectrometry method for therapeutic drug monitoring of 10 β ‐lactam antibiotics, linezolid and two β ‐lactamase inhibitors in human plasma
46. Long‐term chemogenetic suppression of seizures in a multifocal rat model of temporal lobe epilepsy
47. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)
48. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care
49. Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients
50. Development and validation of a liquid chromatography--tandem mass spectrometry assay for the quantification of docetaxel and paclitaxel in human plasma and oral fluid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.